These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 118925)

  • 21. [The significance of respiratory syncytial virus as pathogen in respiratory tract infections in infants (author's transl)].
    Braun F; Lachmann D
    Wien Klin Wochenschr; 1979 Nov; 91(21):715-7. PubMed ID: 516739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model.
    Hemming VG; Prince GA; Horswood RL; London WJ; Murphy BR; Walsh EE; Fischer GW; Weisman LE; Baron PA; Chanock RM
    J Infect Dis; 1985 Nov; 152(5):1083-7. PubMed ID: 4045247
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellular and humoral immunity in recurrent respiratory syncytial virus infections.
    Fernald GW; Almond JR; Henderson FW
    Pediatr Res; 1983 Sep; 17(9):753-8. PubMed ID: 6622111
    [No Abstract]   [Full Text] [Related]  

  • 24. Respiratory syncytial virus ts mutants and nuclear immunofluorescence.
    Faulkner GP; Shirodaria PV; Follett EA; Pringle CR
    J Virol; 1976 Nov; 20(2):487-500. PubMed ID: 62058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis.
    Crowe JE; Bui PT; London WT; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1994 Jun; 12(8):691-9. PubMed ID: 8091846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical manifestations of respiratory tract infections due to respiratory syncytial virus and rhinoviruses in hospitalized children.
    Kellner G; Popow-Kraupp T; Kundi M; Binder C; Kunz C
    Acta Paediatr Scand; 1989 May; 78(3):390-4. PubMed ID: 2545074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.
    Crowe JE; Collins PL; London WT; Chanock RM; Murphy BR
    Vaccine; 1993 Nov; 11(14):1395-404. PubMed ID: 8310760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuated respiratory syncytial virus vaccines in asthmatic children.
    McIntosh K; Arbeter AM; Stahl MK; Orr IA; Hodes DS; Ellis EF
    Pediatr Res; 1974 Jul; 8(7):689-96. PubMed ID: 4601222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.
    Murphy BR; Graham BS; Prince GA; Walsh EE; Chanock RM; Karzon DT; Wright PF
    J Clin Microbiol; 1986 Jun; 23(6):1009-14. PubMed ID: 3754878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by immunofluorescence and ELISA does not justify discontinuation of virus isolation.
    Percivalle E; Zavattoni M; Revello MG; Mariani G; Scaravelli C; Gerna G
    Microbiologica; 1989 Jul; 12(3):203-13. PubMed ID: 2674634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.
    Murphy BR; Prince GA; Walsh EE; Kim HW; Parrott RH; Hemming VG; Rodriguez WJ; Chanock RM
    J Clin Microbiol; 1986 Aug; 24(2):197-202. PubMed ID: 3755730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced isolation of respiratory syncytial virus in cell culture.
    Arens MQ; Swierkosz EM; Schmidt RR; Armstrong T; Rivetna KA
    J Clin Microbiol; 1986 Apr; 23(4):800-2. PubMed ID: 3700634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ontogenesis of the formation of secretory antibodies to respiratory syncytial (RS) virus.
    Leschinskaya NP; Pokrovskaya EE; Kantorovitch EA; Grigorjeva SK; Shvartsman YaS
    Epidemiol Infect; 1988 Dec; 101(3):565-75. PubMed ID: 3215287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological evidence for the association of bovine respiratory syncytial virus with respiratory tract disease in Alabama cattle.
    Rossi CR; Kiesel GK
    Infect Immun; 1974 Aug; 10(2):293-8. PubMed ID: 4854249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme immunoassay for respiratory syncytial virus: rapid detection in nasopharyngeal secretions and evaluation of isolates representing different RSV subgroups.
    Siqueira MM; Nascimento JP; Portes SA; Schuy W
    J Clin Lab Anal; 1993; 7(2):130-3. PubMed ID: 8505698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection.
    Walsh EE; Hall CB; Briselli M; Brandriss MW; Schlesinger JJ
    J Infect Dis; 1987 Jun; 155(6):1198-204. PubMed ID: 3553346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection.
    Bruhn FW; Yeager AS
    Am J Dis Child; 1977 Feb; 131(2):145-8. PubMed ID: 835529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.
    Hall CB; Douglas RG; Simons RL; Geiman JM
    J Pediatr; 1978 Jul; 93(1):28-32. PubMed ID: 206677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses.
    Newman JT; Riggs JM; Surman SR; McAuliffe JM; Mulaikal TA; Collins PL; Murphy BR; Skiadopoulos MH
    J Virol; 2004 Feb; 78(4):2017-28. PubMed ID: 14747566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro cell-dependent lysis of respiratory syncytial virus-infected cells mediated by antibody from local respiratory secretions.
    Cranage MP; Gardner PS; McIntosh K
    Clin Exp Immunol; 1981 Jan; 43(1):28-35. PubMed ID: 7018759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.